Carregant...
Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease
Multicentric Castleman’s disease (MCD) is a rare, widespread lymphoproliferative disorder and a life-threatening disease involving hyperactivity of the immune system, excessive proinflammatory cytokine release, immune cell proliferation, and organ system dysfunction. Interleukin-6 (IL-6) is a cytoki...
Guardat en:
| Publicat a: | Patient Relat Outcome Meas |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769562/ https://ncbi.nlm.nih.gov/pubmed/29391839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S140011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|